Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe

por Deng, Zhaoming, Liao, Wei, Wei, Wei, Zhong, Guihua, He, Chao, Zhang, Hongbo, Liu, Qiaodan, Xu, Xiwei, Liang, Jun, Liu, Zhigang
Publicado 2021

How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19?()

por Wei, Wei, Jiang, Hao, Chen, Weipeng, Zhou, Yuling, Guo, Shuanshuan, Zhong, Guihua, Zhou, Huaili, Wang, Siyang, Zhang, Hongyu, Jiang, Wen, Liu, Zhi-gang
Publicado 2020

Tumor Microbiome in Nasopharyngeal Carcinoma and Its Association With Prognosis

por Zhong, Guihua, Wei, Wei, Liao, Wei, Wang, Rong, Peng, Yingpeng, Zhou, Yuling, Huang, Xiaotao, Xian, Shiping, Peng, Shunli, Zhang, Zhaoyuan, Feng, Shaoyan, Liu, Ye, Hong, Haiyu, Xia, Yunfei, Yan, Yan, Liu, Qiaodan, Liu, Zhigang
Publicado 2022

Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open label, single-arm, phase Ib...

por Huang, Xiaotao, Liu, Qiaodan, Zhong, Guihua, Peng, Yingpeng, Liu, Ye, Liang, Lizhong, Hong, Haiyu, Feng, Weineng, Yang, Shuang, Zhang, Yaqin, Xian, Shiping, Li, Zhanyu, Zhou, Yuling, Zhang, Zhaoyuan, Jiang, Wen, Liang, Jun, Liu, Zhi-gang
Publicado 2022